Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease.
about
Myocardial protective effects of dexmedetomidine in patients undergoing cardiac surgery: A meta-analysis and systematic reviewYear in review in Intensive Care Medicine 2010: III. ARDS and ALI, mechanical ventilation, noninvasive ventilation, weaning, endotracheal intubation, lung ultrasound and paediatrics.A dose-response study of dexmedetomidine administered as the primary sedative in infants following open heart surgery.The hemodynamic response to dexmedetomidine loading dose in children with and without pulmonary hypertensionDexmedetomidine: pediatric pharmacology, clinical uses and safety.Dexmedetomidine: applications for the pediatric patient with congenital heart disease.Dexmedetomidine: antiarrhythmic effects in the pediatric cardiac patient.Dexmedetomidine: a review of applications for cardiac surgery during perioperative period.Anesthetic drugs in congenital heart disease.Bradycardia in perspective-not all reductions in heart rate need immediate intervention.Dexmedetomidine use in patients undergoing electrophysiological study for supraventricular tachyarrhythmias.Dexmedetomidine: therapeutic use for the termination of reentrant supraventricular tachycardia.Dexmedetomidine utilisation and outcomes of children with trisomy 21 undergoing congenital heart disease surgery.Effect of dexmedetomidine on the QT interval in pediatric patients undergoing general anesthesia.Electrocardiographic and electrophysiologic effects of dexmedetomidine on children.Dexmedetomidine controls supraventricular tachycardia following cardiac surgery in a child.Long QT syndrome unmasked by dexmedetomidine: a case report.
P2860
Q33724021-C5AEE5A9-DEF4-4E57-A6C0-0579782922DDQ34588160-227609FB-001D-4C5E-AA30-CAE6D9D425BAQ37038596-B157AA8A-1EB4-483A-829B-90A4A6C3B888Q37315365-B3FFAE32-2E0E-4B9D-B57B-DBE34D625AD9Q37780765-2635534F-5323-4B13-9FDF-B1539113E6E4Q37930472-89406407-A8C6-4291-9ECA-64455ADFC8A6Q38084146-D3A61E33-BF82-46A6-9546-3CADBB0F7033Q38218903-DD8B0597-B64B-43F4-A6F2-71AC74A38712Q38232923-52B0AEAB-9EEA-4548-9561-A799DB00B35CQ38269679-6DE20B0E-FCE7-44CB-88EE-FE185AABD263Q39251517-29990622-3B77-47E7-8FEF-C8C6DB719AA7Q44419734-4F4335B0-4B2D-448B-96FA-0A99EFBECABAQ44805815-15085F57-8FA7-420B-AEF1-DEE313D40B87Q47667577-B98C0BFA-B3E0-4F62-B547-B2BAFA45A1EEQ47738312-A8715757-608F-4E9C-BB84-C7482A3C5661Q47995606-58A476B8-A061-4405-A7A9-D262F0267629Q53809192-44FD1BB0-6177-4F19-B2C5-69A7A7037705
P2860
Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Electrocardiographic effects o ...... with congenital heart disease.
@en
Electrocardiographic effects o ...... with congenital heart disease.
@nl
type
label
Electrocardiographic effects o ...... with congenital heart disease.
@en
Electrocardiographic effects o ...... with congenital heart disease.
@nl
prefLabel
Electrocardiographic effects o ...... with congenital heart disease.
@en
Electrocardiographic effects o ...... with congenital heart disease.
@nl
P2093
P1476
Electrocardiographic effects of dexmedetomidine in patients with congenital heart disease
@en
P2093
Constantinos Chrysostomou
Dana Shiderly
Edmund H Jooste
Peter D Wearden
Ricardo Munoz
Richard Orr
Rukmini Komarlu
Steven Lichtenstein
Victor O Morell
P2888
P304
P356
10.1007/S00134-010-1782-Z
P50
P577
2010-03-06T00:00:00Z